Cefixime
سفیکسیم
🦠 Antiinfectives For Systemic UseThird-generation cephalosporin
Market / country: 🇺🇸 USA
Suprax (US)
🧮 Dose calculator
Acute otitis media · Regimen source: FDA Cefixime · 2.2FDA Cefixime · 1
- • Treat otitis media with the suspension; do not substitute the tablet or capsule. FDA Cefixime · 2.2
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Known allergy to cefixime or other cephalosporins. FDA Cefixime · 4
- ⛔ Safety and effectiveness below 6 months not established. FDA Cefixime · 8.4
Warnings
- • Hypersensitivity reactions FDA Cefixime · 5.1
- • Clostridioides difficile-associated diarrhea FDA Cefixime · 5.2
- • Coagulation effects FDA Cefixime · 5.4
Renal adjustment
- • eGFR < 60: CrCl <60 mL/min: reduce per label Table 2 (adults). FDA Cefixime · 2.3
Formulations
- 100 mg / 5 mL — suspension 🇺🇸 USA FDA Cefixime · 3
- 200 mg / 5 mL — suspension 🇺🇸 USA FDA Cefixime · 3
- 400 mg capsule — capsule 🇺🇸 USA FDA Cefixime · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Cefixime · 8.1
“Risk Summary Available data from published observational studies, case series, and case reports over several decades with cephalosporin use, including cefixime, in pregnant women have not established drug-associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes (see Data) .”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Cefixime · 8.2
“Risk Summary There are no available data on the presence of cefixime in human milk, the effects on the breast-fed infant, or the effects on milk production.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Cefixime · 8.4
“The safety and effectiveness of cefixime have been established in pediatric patients 6 months of age and older.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Cefixime · 8.5
“Clinical studies did not include sufficient numbers of subjects aged 65 and older to determine whether they respond differently than younger subjects.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA065129
- DailyMed (FDA label)FDA Cefixime
- MedlinePlus (NIH)Cefixime
- WHO ATC/DDDJ01DD08
- Darooyab (Iran)Cefixime
🇮🇷 Registered in Iran Darooyab · G-325/Cefixime
Dosage forms with Iranian generic codes, per Darooyab.
- 02419 · CEFIXIME 100MG/5ML 100ML FOR SUSP · سوسپانسیون سفیکسیم ۱۰۰ میلیگرم / ۵ میلیلیتر ۱۰۰ میلیلیتر
- 03849 · CEFIXIME 100MG/5ML 50ML FOR SUSP · سوسپانسیون سفیکسیم ۱۰۰ میلیگرم / ۵ میلیلیتر ۵۰ میلیلیتر
- 02115 · CEFIXIME 100MG/SACHET FOR SUSP · سوسپانسیون سفیکسیم ۱۰۰ میلیگرم
- 07495 · CEFIXIME 200MG CAP · کپسول سفیکسیم ۲۰۰ میلیگرم
- 00226 · CEFIXIME 200MG TAB · قرص سفیکسیم ۲۰۰ میلیگرم
- 07496 · CEFIXIME 400MG CAP · کپسول سفیکسیم ۴۰۰ میلیگرم
- 00227 · CEFIXIME 400MG TAB · قرص سفیکسیم ۴۰۰ میلیگرم
- 00228 · CEFIXIME 50MG/SACHET FOR PED SUSP · سوسپانسیون سفیکسیم ۵۰ میلیگرم / پد
- 51971 · CEFIXIME 100MG/5ML 100ML FOR SUSP · سوسپانسیون سفیکسیم ۱۰۰ میلیگرم / ۵ میلیلیتر ۱۰۰ میلیلیتر
- 51971 · CEFIXIME 200MG/5ML 50ML FOR SUSP · سوسپانسیون سفیکسیم ۲۰۰ میلیگرم / ۵ میلیلیتر ۵۰ میلیلیتر
- 51889 · CEFIXIME POWDER, FOR SUSPENSION ORAL 100 mg/5 mL 50 mL · سوسپانسیون خوراکی سفیکسیم ۱۰۰ میلیگرم / ۵ میلیلیتر ۵۰ میلیلیتر
- 52222 · CEFIXIME TABLET ORAL 400 mg · قرص سفیکسیم ۴۰۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Cefixime · 3FDA Cefixime · 2.2FDA Cefixime · 1FDA Cefixime · 2.2, Table 1FDA Cefixime · 2.1FDA Cefixime · 4FDA Cefixime · 8.4FDA Cefixime · 5.1FDA Cefixime · 5.2FDA Cefixime · 5.4FDA Cefixime · 2.3FDA Cefixime · 8.1FDA Cefixime · 8.2FDA Cefixime · 8.5FDA Cefixime · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-325/Cefixime
- Clinical review⚠ Unverified